That brings the total to 25 drugs that will have lower price tags, which account for a third of Medicare spending on ...

The Centers for Medicare & Medicaid Services says the 15 drugs are Ozempic, Rybelsus and Wegovy; Trelegy Ellipta; Xtandi; ...

Explore the gap between patient and clinician perspectives in psoriatic arthritis care. Learn how priorities differ and why ...

Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's ...

AbbVie closed out the year on a high note, as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s ...

If you live in the United States, you’ve likely seen drug commercials like this one: “If you’re living with moderate to severe plaque psoriasis or active psoriatic arthritis, symptoms can sometimes ...

From weight loss to cancer drugs, subcutaneous injections are popular with patients for their convenience, potentially ...

While both are types of arthritis, there are notable differences While they both fall under the "arthritis" umbrella and share certain similarities, these diseases have significant differences.

To that end, the company has reported positive results for two phase 3 trials of Sotyktu in adult patients who have psoriatic arthritis (PsA). Without revealing figures, BMS said that the POETYK ...

This week also saw a notable surge from pharmaceutical company AbbVie, with their drug Skyrizi, which leaped from 32nd to 4th place. PayPal, T-Mobile, and Vicks also made solid showings ...

Abbvie sales records showed that Skyrizi (risankizumab-rzaa ... Selarsdi is designed to treat conditions like plaque psoriasis, psoriatic arthritis, Crohn disease, and ulcerative colitis, and its ...